Nathalie D. Harder

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 12, 2024

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer.

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer.

Journal: Scientific reports

Published: December 11, 2023

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.

Journal: The Journal of clinical investigation

Published: March 09, 2023

Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker.

Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker.

Journal: Frontiers in oncology

Published: June 08, 2022

Beamlet scraping and its influence on the beam divergence at the BATMAN Upgrade test facility.

Beamlet scraping and its influence on the beam divergence at the BATMAN Upgrade test facility.

Journal: The Review of scientific instruments

Published: February 05, 2020

Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma.

Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma.

Journal: Scientific reports

Published: December 04, 2018

Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer.

Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer.

Journal: Scientific reports

Published: October 11, 2017

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 30, 2017

An objective comparison of cell-tracking algorithms.

An objective comparison of cell-tracking algorithms.

Journal: Nature methods

Published: June 03, 2017

The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells.

The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells.

Journal: Scientific reports

Published: February 01, 2017

iDermatoPath - a novel software tool for mitosis detection in H&E-stained tissue sections of malignant melanoma.

iDermatoPath - a novel software tool for mitosis detection in H&E-stained tissue sections of malignant melanoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 22, 2016

High-Throughput RNAi Screening Identifies a Role for the Osteopontin Pathway in Proliferation and Migration of Human Aortic Smooth Muscle Cells.

High-Throughput RNAi Screening Identifies a Role for the Osteopontin Pathway in Proliferation and Migration of Human Aortic Smooth Muscle Cells.

Journal: Cardiovascular drugs and therapy

Published: April 21, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026